NBC News Politics

FDA moves to fast-track three psychedelic drugs for review

YesterdayCenter Left

A day after the DOJ said it would ease restrictions on medical marijuana, the FDA moves to fast-track some experimental psychedelic drugs for review. They're looking at three drugs for treatment-resistant depression, major depressive disorder, and PTSD. NBC's Anne Thompson reports.

Read Full Story at Source

Compare Perspectives

No matches found in this bias.

No direct matches found for "FDA moves fasttrack three psychedelic" in this bias range.